Home     >     About     >     News

Division News


Robbie Majzner, MD Recieves 2018 St. Baldrick's Scholar Award

July 18, 2018

Dr. Majzner is one of 11 recipients of a 2018 St. Baldrick's Scholar Award for his innovative work using CAR T cell therapies to target high-grade gliomas.

Michael Link, MD on Nelarabine in Newly Diagnosed T-Cell Malignancies

July 9, 2018

Michael Link, MD, Lydia J. Lee Professor in Pediatric Cancer, professor, Pediatrics, Stanford Cancer Institute, and a 2018 Giant of Cancer Care in Pediatric Oncology, discusses the randomized trial testing nelarabine in patients with T-cell malignancies.


Congratulations to Meena Kadapakkam, MD & Sara Kreimer, MD

Congratulations to Meena Kadapakkam, MD and Sara Kreimer, MD for completing the Pediatric Hematology/Oncology Fellowship training program!


Kathleen Sakamoto, MD, PhD Receives the Hyundai Scholar Award

2018

Kathleen Sakamoto, MD, PhD receives the Hyundai Scholar Award and recognized for her efforts to increase treatment options and to improve the quality of life for children with cancer. This highly-competitive grant are selected by a rigorous scientific review panel and awards a three-year grant totaling $300,000.


Why does CAR-T cancer therapy give this Stanford oncologist hope? Watch this video

March 27, 2018

By Kris Newby

Crystal Mackall, MD, a Stanford professor of pediatric oncology/hematology, recently sat down with me to explain why she’s so optimistic about the future of CAR-T therapy for treating cancer.

IN THE SPOTLIGHT

Mackall awarded $11.9 million for anti-leukemia clinical trial

The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.